758 related articles for article (PubMed ID: 24462078)
21. Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma?
Ramacciato G; Mercantini P; Petrucciani N; Giaccaglia V; Nigri G; Ravaioli M; Cescon M; Cucchetti A; Del Gaudio M
Ann Surg Oncol; 2009 Apr; 16(4):817-25. PubMed ID: 19156463
[TBL] [Abstract][Full Text] [Related]
22. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.
Martin RC; Scoggins CR; Egnatashvili V; Staley CA; McMasters KM; Kooby DA
Arch Surg; 2009 Feb; 144(2):154-9. PubMed ID: 19221327
[TBL] [Abstract][Full Text] [Related]
23. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286
[TBL] [Abstract][Full Text] [Related]
24. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
[TBL] [Abstract][Full Text] [Related]
25. Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis.
Chu CK; Farnell MB; Nguyen JH; Stauffer JA; Kooby DA; Sclabas GM; Sarmiento JM
J Am Coll Surg; 2010 Sep; 211(3):316-24. PubMed ID: 20800187
[TBL] [Abstract][Full Text] [Related]
26. Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Nakagawa N; Sueda T
J Surg Oncol; 2013 Mar; 107(4):414-21. PubMed ID: 22886567
[TBL] [Abstract][Full Text] [Related]
27. Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis.
Yu XZ; Li J; Fu DL; Di Y; Yang F; Hao SJ; Jin C
Eur J Surg Oncol; 2014 Apr; 40(4):371-8. PubMed ID: 24560302
[TBL] [Abstract][Full Text] [Related]
28. Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinoma.
Kim PT; Wei AC; Atenafu EG; Cavallucci D; Cleary SP; Moulton CA; Greig PD; Gallinger S; Serra S; McGilvray ID
Br J Surg; 2013 Sep; 100(10):1349-56. PubMed ID: 23939847
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
[TBL] [Abstract][Full Text] [Related]
31. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy.
van Geenen RC; ten Kate FJ; de Wit LT; van Gulik TM; Obertop H; Gouma DJ
Surgery; 2001 Feb; 129(2):158-63. PubMed ID: 11174708
[TBL] [Abstract][Full Text] [Related]
32. Pancreaticoduodenectomy with vascular resection: margin status and survival duration.
Tseng JF; Raut CP; Lee JE; Pisters PW; Vauthey JN; Abdalla EK; Gomez HF; Sun CC; Crane CH; Wolff RA; Evans DB
J Gastrointest Surg; 2004 Dec; 8(8):935-49; discussion 949-50. PubMed ID: 15585381
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
Banz VM; Croagh D; Coldham C; Tanière P; Buckels J; Isaac J; Mayer D; Muiesan P; Bramhall S; Mirza DF
Eur J Surg Oncol; 2012 Jan; 38(1):72-9. PubMed ID: 22054617
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH
Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
[TBL] [Abstract][Full Text] [Related]
35. Indications and techniques of extended resection for pancreatic cancer.
Nakao A; Takeda S; Inoue S; Nomoto S; Kanazumi N; Sugimoto H; Fujii T
World J Surg; 2006 Jun; 30(6):976-82; discussion 983-4. PubMed ID: 16736324
[TBL] [Abstract][Full Text] [Related]
36. One Hundred Pancreatectomies with Venous Resection for Pancreatic Adenocarcinoma.
Dumitrascu T; Martiniuc A; Brasoveanu V; Stroescu C; David L; Dima S; Stanciulea O; Ionescu M; Popescu I
Chirurgia (Bucur); 2018; 113(3):363-373. PubMed ID: 29981667
[No Abstract] [Full Text] [Related]
37. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
38. Direct percutaneous transhepatic portomesenteric venous stenting in management of locally advanced pancreatic cancer.
Alden D; Dudiy Y; Nassiri N; Friedland RJ; Amatulle P; Rosen RJ
Am J Clin Oncol; 2015 Apr; 38(2):127-9. PubMed ID: 23608832
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
[TBL] [Abstract][Full Text] [Related]
40. Results of portosystemic shunts during extended pancreatic resections.
Oehme F; Distler M; Müssle B; Kahlert C; Weitz J; Welsch T
Langenbecks Arch Surg; 2019 Dec; 404(8):959-966. PubMed ID: 31446472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
